PET with a Ga-Labeled FAPI Dimer: Moving Toward Theranostics.
作者信息
Younis Muhsin H, Lan Xiaoli, Cai Weibo
机构信息
Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; and
出版信息
J Nucl Med. 2022 Jun;63(6):860-861. doi: 10.2967/jnumed.121.263292. Epub 2021 Nov 5.
Abstract
摘要
相似文献
1
PET with a Ga-Labeled FAPI Dimer: Moving Toward Theranostics.镓标记的FAPI二聚体正电子发射断层显像：迈向诊疗一体化
J Nucl Med. 2022 Jun;63(6):860-861. doi: 10.2967/jnumed.121.263292. Epub 2021 Nov 5.
2
Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics.新型 FAPI-04 二聚体用于癌症诊疗一体化的合成与初步评价。
Mol Pharm. 2023 May 1;20(5):2402-2414. doi: 10.1021/acs.molpharmaceut.2c00965. Epub 2023 Apr 4.
3
Ga-DOTA-RGD Positron Emission Tomography/Computed Tomography in Radioiodine Refractory Thyroid Cancer: Prospective Comparison of Diagnostic Accuracy with F-FDG Positron Emission Tomography/Computed Tomography and Evaluation Toward Potential Theranostics.镓-DOTA-RGD 正电子发射断层扫描/计算机断层扫描在放射性碘难治性甲状腺癌中的应用：与 F-FDG 正电子发射断层扫描/计算机断层扫描的诊断准确性的前瞻性比较及潜在治疗学评估。
Thyroid. 2020 Apr;30(4):557-567. doi: 10.1089/thy.2019.0450. Epub 2020 Jan 23.
4
Clinical utility of [Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma.镓[68Ga]标记成纤维细胞激活蛋白抑制剂（FAPI）正电子发射断层扫描/计算机断层扫描在鼻咽癌原发分期和复发检测中的临床应用。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3606-3617. doi: 10.1007/s00259-021-05336-w. Epub 2021 Apr 1.
5
A theranostic approach of [Ga]Ga-DOTA.SA.FAPi PET/CT-guided [Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy.[镓]镓-DOTA.SA.FAPi PET/CT引导下的[镥]镥-DOTA.SA.FAPi放射性核素治疗在一名晚期乳腺癌患者中的诊疗一体化方法：靶向放射性核素治疗的新前沿
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944. doi: 10.1007/s00259-020-04990-w. Epub 2020 Aug 11.
6
Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.镓-FAPI PET/CT：不同癌症患者中两种含 DOTA 的 FAP 靶向剂的生物分布和初步剂量估算。
J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2.
7
Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.镓-FAPI PET/CT：28 种不同癌症的示踪剂摄取。
J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.
8
Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of Ga-Labeled FAPI Dimer.镓标记的 FAPI 二聚体的合成、临床前评估和初步临床 PET 成像研究。
J Nucl Med. 2022 Jun;63(6):862-868. doi: 10.2967/jnumed.121.263016. Epub 2021 Sep 23.
9
Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation.成纤维细胞活化蛋白抑制剂治疗学：早期临床转化。
PET Clin. 2023 Jul;18(3):419-428. doi: 10.1016/j.cpet.2023.02.007. Epub 2023 Apr 6.
10
The Application of [Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.[Ga]-标记 FAPI-04 PET/CT 在患者来源的原位异种移植模型中用于胰腺癌细胞靶向和早期检测的应用。
Contrast Media Mol Imaging. 2022 Aug 5;2022:6596702. doi: 10.1155/2022/6596702. eCollection 2022.
引用本文的文献
1
[Ga]Ga-DOTAGA-Glu(FAPi) Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging.[镓]镓-DOTAGA-谷氨酸（FAPi）在临床前PET成像中显示出增强的肿瘤摄取和诊疗潜力。
Diagnostics (Basel). 2024 Sep 13;14(18):2024. doi: 10.3390/diagnostics14182024.
2
Imageological/Structural Study regarding the Improved Pharmacokinetics by Ga-Labeled PEGylated PSMA Multimer in Prostate Cancer.关于镓标记的聚乙二醇化前列腺特异性膜抗原多聚体改善前列腺癌药代动力学的影像学/结构研究
Pharmaceuticals (Basel). 2023 Apr 14;16(4):589. doi: 10.3390/ph16040589.
3
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics.基于FAP抑制剂的新型同二聚体的生成，用于改进在放射治疗诊断中的应用。
Cancers (Basel). 2023 Mar 21;15(6):1889. doi: 10.3390/cancers15061889.
本文引用的文献
1
Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.白蛋白结合物偶联成纤维细胞激活蛋白抑制剂放射性药物用于癌症治疗。
J Nucl Med. 2022 Jun;63(6):952-958. doi: 10.2967/jnumed.121.262533. Epub 2021 Sep 30.
2
Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of Ga-Labeled FAPI Dimer.镓标记的 FAPI 二聚体的合成、临床前评估和初步临床 PET 成像研究。
J Nucl Med. 2022 Jun;63(6):862-868. doi: 10.2967/jnumed.121.263016. Epub 2021 Sep 23.
3
Feasibility and Therapeutic Potential of 177Lu-Fibroblast Activation Protein Inhibitor-46 for Patients With Relapsed or Refractory Cancers: A Preliminary Study.177Lu-成纤维细胞激活蛋白抑制剂-46用于复发或难治性癌症患者的可行性及治疗潜力：一项初步研究
Clin Nucl Med. 2021 Nov 1;46(11):e523-e530. doi: 10.1097/RLU.0000000000003810.
4
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.FAPI-PET 成像的最新技术：系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4396-4414. doi: 10.1007/s00259-021-05475-0. Epub 2021 Jun 25.
5
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using Lu-FAP-2286: First-in-Humans Results.使用镥- FAP - 2286对多种腺癌进行肽靶向放射性核素治疗的可行性、生物分布及初步剂量测定：首例人体研究结果
J Nucl Med. 2022 Mar;63(3):415-423. doi: 10.2967/jnumed.120.259192. Epub 2021 Jun 24.
6
Clinical utility of [Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma.镓[68Ga]标记成纤维细胞激活蛋白抑制剂（FAPI）正电子发射断层扫描/计算机断层扫描在鼻咽癌原发分期和复发检测中的临床应用。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3606-3617. doi: 10.1007/s00259-021-05336-w. Epub 2021 Apr 1.
7
The Latest Developments in Imaging of Fibroblast Activation Protein.成纤维细胞激活蛋白成像的最新进展。
J Nucl Med. 2021 Feb;62(2):160-167. doi: 10.2967/jnumed.120.244806. Epub 2020 Oct 30.
8
Usefulness of [Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [F]FDG PET/CT findings.[Ga]Ga-DOTA-FAPI-04 PET/CT 在 [F]FDG PET/CT 结果不确定的患者中的应用价值。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):73-86. doi: 10.1007/s00259-020-04940-6. Epub 2020 Jun 25.
9
[Ga]Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer.[镓]镓-多胺多羧基配体-纤维连接蛋白激活肽-04改善了一名食管癌患者的肿瘤分期，并监测了其对放化疗的早期反应。
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3188-3189. doi: 10.1007/s00259-020-04818-7. Epub 2020 Apr 24.
10
Comparison of [Ga]Ga-DOTA-FAPI-04 and [F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.[镓]Ga-DOTA-FAPI-04与[氟]FDG PET/CT在各类癌症患者原发性和转移性病变诊断中的比较。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1820-1832. doi: 10.1007/s00259-020-04769-z. Epub 2020 Mar 28.
Zotero 插件